Research ExplorerPublicationsRhabdomyolysis after Concomitant Use of Statins and Antibiot...

Rhabdomyolysis after Concomitant Use of Statins and Antibiotics

Standard

Rhabdomyolysis after Concomitant Use of Statins and Antibiotics. / Paparoupa, Maria; Ho, Huy; Gillissen, Adrian.

Coronary Artery Disease: Causes, Symptoms and Treatments. . Vol. 3 iConcept Press, 2016.

Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review

Harvard

Paparoupa, M, Ho, H & Gillissen, A 2016, Rhabdomyolysis after Concomitant Use of Statins and Antibiotics. in Coronary Artery Disease: Causes, Symptoms and Treatments. . vol. 3 , iConcept Press.

APA

Paparoupa, M., Ho, H., & Gillissen, A. (2016). Rhabdomyolysis after Concomitant Use of Statins and Antibiotics. In Coronary Artery Disease: Causes, Symptoms and Treatments. (Vol. 3 ). iConcept Press.

Vancouver

Paparoupa M, Ho H, Gillissen A. Rhabdomyolysis after Concomitant Use of Statins and Antibiotics. In Coronary Artery Disease: Causes, Symptoms and Treatments. . Vol. 3 . iConcept Press. 2016

Bibtex

@inbook{8c05793382b64ec1a53de90210087b7a,
title = "Rhabdomyolysis after Concomitant Use of Statins and Antibiotics",
abstract = "Statins have a well demonstrated effect on cardiovascular health and have been systematically used as an integral part of primary and secondary prevention of coronary artery disease. As a widely prescribed medication worldwide, statins have been reported to induce several drug-drug interactions which sometimes can be so severe that lead to discontinuation of the treatment. More common are adverse events under co-administration of statins and antibiotics. Several mechanisms are proposed to be involved to these interactions, such as elimination of the statins´ liver metabolism through inhibition of cytochromes CYP 3A4 and CYP 2C8 and inhibition of the cellular drug efflux-transporter. The main side effect to be reported is myotoxicity, while rhabdomyolysis with acute renal injury and elevation of liver enzymes is the most severe form. This review intends to provide an insight of the current reported statins-antibiotics interactions leading to rhabdomyolysis and the mechanisms to be involved.",
author = "Maria Paparoupa and Huy Ho and Adrian Gillissen",
year = "2016",
language = "English",
volume = "3 ",
booktitle = "Coronary Artery Disease: Causes, Symptoms and Treatments.",
publisher = "iConcept Press",

}

RIS

TY - CHAP

T1 - Rhabdomyolysis after Concomitant Use of Statins and Antibiotics

AU - Paparoupa, Maria

AU - Ho, Huy

AU - Gillissen, Adrian

PY - 2016

Y1 - 2016

N2 - Statins have a well demonstrated effect on cardiovascular health and have been systematically used as an integral part of primary and secondary prevention of coronary artery disease. As a widely prescribed medication worldwide, statins have been reported to induce several drug-drug interactions which sometimes can be so severe that lead to discontinuation of the treatment. More common are adverse events under co-administration of statins and antibiotics. Several mechanisms are proposed to be involved to these interactions, such as elimination of the statins´ liver metabolism through inhibition of cytochromes CYP 3A4 and CYP 2C8 and inhibition of the cellular drug efflux-transporter. The main side effect to be reported is myotoxicity, while rhabdomyolysis with acute renal injury and elevation of liver enzymes is the most severe form. This review intends to provide an insight of the current reported statins-antibiotics interactions leading to rhabdomyolysis and the mechanisms to be involved.

AB - Statins have a well demonstrated effect on cardiovascular health and have been systematically used as an integral part of primary and secondary prevention of coronary artery disease. As a widely prescribed medication worldwide, statins have been reported to induce several drug-drug interactions which sometimes can be so severe that lead to discontinuation of the treatment. More common are adverse events under co-administration of statins and antibiotics. Several mechanisms are proposed to be involved to these interactions, such as elimination of the statins´ liver metabolism through inhibition of cytochromes CYP 3A4 and CYP 2C8 and inhibition of the cellular drug efflux-transporter. The main side effect to be reported is myotoxicity, while rhabdomyolysis with acute renal injury and elevation of liver enzymes is the most severe form. This review intends to provide an insight of the current reported statins-antibiotics interactions leading to rhabdomyolysis and the mechanisms to be involved.

M3 - SCORING: Contribution to collected editions/anthologies

VL - 3

BT - Coronary Artery Disease: Causes, Symptoms and Treatments.

PB - iConcept Press

ER -